Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Failed $ 1.4 million PP in Sept 2021 = FINANCIAL DIFFICULTY
View:
Post by deepoil0808 on Nov 09, 2021 1:31am

Failed $ 1.4 million PP in Sept 2021 = FINANCIAL DIFFICULTY

MEDV failed to close a $ 1.4 million private placement at 7 cents in September 2021.   This FAILURE speaks volumes of the pending financial results which should confirm FINANCIAL DIFFICULTY and losses.    An investor would not walk away from a 7 cent PP if the pending results were great.   They would have loaded up but instead they walked away. 

Plus results are hampered further because Hampton East closed down, 2 cubes under investigation in California and, Pandemic ending January 4th, 2022 per Pfizer.

There is a reason why MEDV is in panic mode and wants to do a 1 for 15 reverse stock split as they can see the writing on the wall.   Without more funds, it is belly up.   


From the REALIST FROSTY RELIGION


Here is the failed PP

CAN $1.4 Million Equity Private Placement

This investment will be in the form of a non-brokered private placement offering of units (the "Equity Units") at a price of $0.07 per Equity Unit for aggregate gross proceeds of up to $1.4 million (the "Offering"). Each Equity Unit will consist of one common share of the Company and one common share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to acquire one common share of the Company at a price of $0.08 for a period of five years following the closing date of the Offering. The Offering is expected to close on or about September 9, 2021 and may close in tranches.

Comment by Frosted on Nov 09, 2021 7:49am
Said company that walked away from a 7 cent PP CLEARLY lacked vision. Stan saw an opportunity to ti invest in a company that is focused on Telehealth. The proof is the the pudding when tomorrow, Stan does NOTHING. That in itself WILL speak volumes on where we are headed. An allegeded stock reversal does, and I repeat, does NOT happen overnight. MEDV's SP will be on the rise in short order and ...more  
Comment by podatlis1 on Nov 09, 2021 8:24am
Yippi..
Comment by podatlis1 on Nov 09, 2021 8:25am
Yippi..
Comment by podatlis1 on Nov 09, 2021 8:27am
frost or deep.. who will emerge the victor..
Comment by FiduciaryResp on Nov 09, 2021 9:54am
FIND OUT ON THE NEXT EPISODE OF: COPRF BULLBOARD - AIDS EDITION
Comment by podatlis1 on Nov 09, 2021 11:48am
lolol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities